An OCD Prevention Programme for at Risk Adults

Last updated: April 16, 2025
Sponsor: Babes-Bolyai University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Obsessive-compulsive Disorder

Mood Disorders

Panic Disorders

Treatment

Prevention

Clinical Study ID

NCT06262464
17.361/ 07.12.2023
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of tertiary prevention.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • age over 18

Exclusion

Exclusion Criteria:

  • clinically diagnosed OCD

  • current psychiatric/psychotherapeutic treatment

  • personality disorder diagnosis

  • suicidal ideation

Study Design

Total Participants: 200
Treatment Group(s): 1
Primary Treatment: Prevention
Phase:
Study Start date:
February 09, 2024
Estimated Completion Date:
December 31, 2025

Study Description

After being informed about the study and giving written informed consent, all eligible participants will be randomised into the experimental group or the control group (TAU). Participants will be blind to the group allocation.

The experimental group will undergo a two weeks OCD prevention program, consisting of three group sessions per week.

The control group will not receive any intervention.

Researchers will compare the experimental group to the control group to test wether the prevention programme is efficient in reducing OCD symptomatology.

Connect with a study center

  • Babes-Bolyai University, Faculty of Psychology and Educational Sciences, Department of Clinical Psychology and Psychotherapy

    Cluj-Napoca, 400015
    Romania

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.